JNJ's Janssen Pharma Reports FDA Approval For TALVEY To Treat Heavily Pretreated Multiple Myeloma

Press/Media

Period	10 Aug 2023

Media coverage

Title	JNJ's Janssen Pharma Reports FDA Approval For TALVEY To Treat Heavily Pretreated Multiple Myeloma
Media name/outlet	dpa-AFX International ProFeed
Country/Territory	Germany
Date	10/08/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=68X6-8BJ1-J9XT-N00R-00000-00
Persons	Ajai Chari